ARCHIVES

NCI Places Hold On Genentech Drug Trials, Citing Disagreement Over Intellectual Property Provisions.

This article is from The Cancer Letter archive.

Vol. 36 No. 09 | March 12, 2010

Download PDF Visit The Full Archive

Related Articles

NCI Plans $38 Million For New Research In Tobacco Control Over Next Two Years

October 16, 1998

UCLA, NYU, Ohio States Must Wait Longer For Comprehensive Status

November 28, 1975

No Cancer Letter For Next Two Weeks

August 19, 1994

Mammography Controversy Continues: Task Force Alters Web Site To Clarify Recommendation On Mammography

December 4, 2009

Senate Orders OMB T Increase NIH FTEs, Drop Rules On Apportionment

September 19, 1986

Rauscher Responds To Criticism

March 21, 1975